EARLY AND LATE RESPONSE ASSESSMENT WITH FDG-PET AFTER BEACOPP-BASED CHEMOTHERAPY IN ADVANCED-STAGE HODGKIN LYMPHOMA PATIENTS HAS A HIGH NEGATIVE PREDICTIVE VALUE

被引：0
|
作者：
Markova, J. [1 ]
Kobe, C. [2 ]
Skopalova, M. [3 ]
Zikavska, L. [1 ]
Vernerova, Z. [1 ]
Klaskova, K. [1 ]
Dedeckova, K. [4 ]
Eich, H. T. [5 ]
Dietlein, M. [2 ]
Fuchs, M. [6 ]
Engert, A. [7 ]
Kozak, T. [1 ]
机构：
[1] Univ Hosp Kralovske Vinohrady, Prague 0, Czech Republic
[2] Univ Cologne, Dept Nucl Med, D-50924 Cologne, Germany
[3] Na Homolce Hosp, PET Ctr, Dept Nucl Med, Prague, Czech Republic
[4] Univ Hosp Na Bulovce, Inst Radiat Oncol, Prague 8, Czech Republic
[5] Univ Cologne, Dept Radiat Oncol, D-50924 Cologne, Germany
[6] Univ Cologne, German Hodgkin Study Grp, D-50924 Cologne, Germany
[7] Univ Cologne, Dept Internal Med 1, D-50924 Cologne, Germany
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0084
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [21] EARLY DETERMINATION OF TREATMENT SENSITIVITY IN HODGKIN LYMPHOMA: FDG-PET/CT AFTER ONE CYCLE OF THERAPY HAS A HIGHER NEGATIVE PREDICTIVE VALUE THAN AFTER TWO CYCLES OF CHEMOTHERAPY
    Hutchings, M.
    Kostakoglu, L.
    Zaucha, J. M.
    Malkowski, B.
    Biggi, A.
    Danielewicz, I.
    Loft, A.
    Specht, L.
    Coleman, M.
    ANNALS OF ONCOLOGY, 2011, 22 : 138 - 139
  • [22] Early assessment of response to chemotherapy by FDG-PET is highly predictive of outcome in patients with high-grade non-Hodgkin's lymphoma (NHL)
    Jerusalem, G
    Beguin, Y
    Fassotte, MF
    Najjar, F
    Paulus, P
    Rigo, R
    Fillet, G
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S25 - S25
  • [23] Early assessment of response chemotherapy by FDG-PET is highly predictive of outcome in patients with high-grade non-Hodgkin's lymphoma (NHL).
    Jerusalem, G
    Beguin, Y
    Fassotte, MF
    Najjar, F
    Paulus, P
    Rigo, P
    Fillet, G
    BLOOD, 1997, 90 (10) : 1728 - 1728
  • [24] Assessment of Residual Bulky Tumor Using FDG-PET In Patients with Advanced-Stage Hodgkin Lymphoma After Completion of Chemotherapy: Final Report of the GHSG HD15 Trial
    Engert, Andreas
    Kobe, Carsten
    Markova, Jana
    Haverkamp, Heinz
    Borchmann, Peter
    Hitz, Felicitas
    Zijlstra, Josee
    Eich, Hans
    Mueller, Rolf-Peter
    Dietlein, Markus
    Diehl, Volker
    BLOOD, 2010, 116 (21) : 336 - 336
  • [25] Assessment of residual bulky tumor using FDG-PET in patients with advanced-stage Hodgkin Lymphoma after completion of chemotherapy: Final report of the GHSG HD15 trial
    Eich, H. T.
    Kobe, C.
    Kriz, J.
    Baues, C.
    Haverkamp, H.
    Fuchs, M.
    Dietlein, M.
    Engert, A.
    Mueller, R. -P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 48 - 48
  • [26] Early chemotherapy de-escalation strategy in patients with advanced-stage Hodgkin lymphoma with negative positron emission tomography scan after 2 escalated BEACOPP cycles
    Dlugosz-Danecka, Monika
    Szmit, Sebastian
    Kocurek, Anna
    Kozlik, Pawel
    Giza, Agnieszka
    Zimowska-Curylo, Dagmara
    Malkowski, Bogdan
    Sowa-Staszczak, Anna
    Kuzdzal, Jaroslaw
    Jurczak, Wojciech
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2019, 129 (04): : 259 - 266
  • [27] Advanced stage Hodgkin lymphoma: The predictive value on treatment outcome of early FDG-PET scan is independent of and superior to IPS score.
    Gallamini, A.
    Hutchings, M.
    Rigacci, L.
    Specht, L.
    Merli, F.
    D'Amore, F.
    Nassi, L.
    Hansen, M.
    Vitolo, U.
    Kamper, P.
    Trentin, L.
    Stelitano, C.
    Di Raimondo, F.
    Sancetta, R.
    Luminari, S.
    Viviani, S.
    Iannitto, E.
    Levis, A.
    BLOOD, 2006, 108 (11) : 228B - 228B
  • [28] FDG-PET TO GUIDE RADIOTHERAPY IN ADVANCED-STAGE HODGKIN LYMPHOMA PATIENTS WITH RESIDUAL BULKY DISEASE AFTER CHEMOTHERAPY: RESULTS OF THE GHSG HD15 TRIAL
    Engert, A.
    Kobe, C.
    Markova, J.
    Haverkamp, H.
    Borchmann, P.
    Hitz, F.
    Zijlstra, J.
    Eich, H.
    Mueller, R.
    Schicha, H.
    Diehl, V.
    ANNALS OF ONCOLOGY, 2011, 22 : 96 - 96
  • [29] EARLY PREDICTIVE VALUE POST CHEMOTHERAPY OF METABOLIC RESPONSE ASSESSMENT USING FDG-PET IN NSCLC
    Meniawy, T.
    Davidson, A.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S26 - S26
  • [30] The use of FDG-PET to guide consolidative radiotherapy in patients with advanced-stage Hodgkin lymphoma with residual abnormalities on CT scan following ABVD chemotherapy
    Savage, K. J.
    Connors, J. M.
    Klasa, R. J.
    Hoskins, P.
    Shenkier, T. N.
    Gascoyne, R. D.
    Bhimji, S.
    Pickles, T.
    Benard, F.
    Wilson, D.
    Sehn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345